{"id":"W2063908296","doi":"10.3747/co.22.2210","title":"Use of Bevacizumab as a First-Line Treatment for Metastatic Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Celgene; AstraZeneca","keywords":"Bevacizumab; Medicine; Metastatic breast cancer; Oncology; Breast cancer; Chemotherapy; Disease; Internal medicine; Clinical trial; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001808984,0.0002848352,0.000665251,0.0008445692,0.0001660174,0.0007042298,0.0003820367,0.0006078364,0.00177262],"category_scores_gemma":[0.004368826,0.00009596322,0.0005929148,0.0006733984,0.0003051187,0.0004134814,0.0002491323,0.0007505278,0.0004236898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008631101,"about_ca_system_score_gemma":0.001309301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001236788,"about_ca_topic_score_gemma":0.002679312,"domain_scores_codex":[0.9988159,0.0006059802,0.000121395,0.0001315683,0.000271944,0.0000532333],"domain_scores_gemma":[0.9977161,0.001129057,0.0005915492,0.00004810217,0.0004300408,0.00008514211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0009718074,0.0001263633,0.004662445,0.02082966,0.0008608087,0.0008303574,0.0001566731,0.0007203759,0.009341758,0.001962032,0.02591569,0.9336219],"study_design_scores_gemma":[0.0005732744,0.002228376,0.03119594,0.02876779,0.001862685,0.01071561,0.0002658243,0.0007955621,0.01294857,0.002029265,0.9085601,0.00005704806],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.003852043,0.9881769,0.0005654641,0.003107968,0.000292392,0.00001909594,0.00004529984,0.00001886938,0.003921904],"genre_scores_gemma":[0.1166877,0.8743594,0.002709817,0.003514156,0.0009448436,0.00006078556,0.0001952006,0.00001477548,0.001513319],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001808984,"threshold_uncertainty_score":0.009566963,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4695800343564018,"score_gpt":0.5319005441505176,"score_spread":0.0623205097941158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}